Alex Graudenzi

9PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Sequence analysisGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2025
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors.

Matteo Villa, Federica Malighetti, Luca De Sano

|Jun 11, 2025
Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm.

Erica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos

|Feb 03, 2025
Early tolerance and late persistence as alternative drug responses in cancer.

Simona Punzi, Davide Cittaro, Guido Gatti

|Sep 25, 2023
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients.

Diletta Fontana, Ilaria Crespiatico, Valentina Crippa

|Jan 21, 2023
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples.

Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti

|May 13, 2022
Variant calling from scRNA-seq data allows the assessment of cellular identity in patient-derived cell lines.

Daniele Ramazzotti, Fabrizio Angaroni, Davide Maspero

Pageof 2